AV
Live price temporarily unavailable.
Price history
Atea Pharmaceuticals Inc (AVIR) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: October 30, 2020 · $24.00 offering · NASDAQ · View IPO details →
Recent News (2)
-
Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patients Without Cirrhosis Supporting a Potential Best-in-Class Profile of BEM/RZR for Treatment of HCV
-
Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International